MedPath

A comparison of Desflurane and propofol in terms of inflammatory potential and impact on respiratory sytem in obese patients undergoing laparoscopic bariatric surgeries

Not Applicable
Conditions
Health Condition 1: E669- Obesity, unspecified
Registration Number
CTRI/2020/03/024154
Lead Sponsor
All India Institute of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. BMI >30 kg/m2

2. ASA Status II

3. Patients scheduled for elective laparoscopic bariatric surgery

Exclusion Criteria

1. Patient refusal

2. ASA III, IV

3. Known allergy to propofol

4. Impaired cardiopulmonary, hepatic, renal function

5. History of chronic inflammation or treatment with immunosuppressants

6. Malignancy

7. Active smoking

8. Obstructive or restrictive lung disease

9. Alcohol dependent currently

10. Pre-existing coagulation disorders

11. Active or resolving pulmonary or systemic infection

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare plasma concentration of interleukin (IL)-6 in patients anaesthetised with propofol and desfluraneTimepoint: prior to induction of anaesthesia (baseline), <br/ ><br>just after induction (T1) <br/ ><br>just before extubation (T3)
Secondary Outcome Measures
NameTimeMethod
Measurement of Airway resistance using impulse oscillometry in both groupsTimepoint: pre-operatively (On admission) <br/ ><br>post-operatively (24 hours after surgery);Respiratory parameters [Tidal volume, respiratory rate, Peak and plateau pressures, driving pressure, compliance, SpO2, PaO2/FiO2 (oxygenation)] in both groupsTimepoint: just after induction (T1) <br/ ><br>30 mins after pneumoperitoneum (T2) <br/ ><br>just before extubation (T3) <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath